124 related articles for article (PubMed ID: 12438152)
1. Structural and biological characterization of chromofungin, the antifungal chromogranin A (47-66)-derived peptide.
Lugardon K; Chasserot-Golaz S; Kieffer AE; Maget-Dana R; Nullans G; Kieffer B; Aunis D; Metz-Boutigue MH
Ann N Y Acad Sci; 2002 Oct; 971():359-61. PubMed ID: 12438152
[TBL] [Abstract][Full Text] [Related]
2. Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide.
Lugardon K; Chasserot-Golaz S; Kieffer AE; Maget-Dana R; Nullans G; Kieffer B; Aunis D; Metz-Boutigue MH
J Biol Chem; 2001 Sep; 276(38):35875-82. PubMed ID: 11451958
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal domain of chromogranin A (CgA1-40) interacts with monolayers of membrane lipids of fungal and mammalian compositions.
Maget-Dana R; Metz-Boutigue MH; Helle KB
Ann N Y Acad Sci; 2002 Oct; 971():352-4. PubMed ID: 12438150
[No Abstract] [Full Text] [Related]
4. Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery.
Mandalà M; Brekke JF; Serck-Hanssen G; Metz-Boutigue MH; Helle KB
Regul Pept; 2005 Jan; 124(1-3):73-80. PubMed ID: 15544843
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity: involvement of new neuropeptides.
Metz-Boutigue MH; Kieffer AE; Goumon Y; Aunis D
Trends Microbiol; 2003 Dec; 11(12):585-92. PubMed ID: 14659691
[TBL] [Abstract][Full Text] [Related]
6. Antifungal coating by biofunctionalized polyelectrolyte multilayered films.
Etienne O; Gasnier C; Taddei C; Voegel JC; Aunis D; Schaaf P; Metz-Boutigue MH; Bolcato-Bellemin AL; Egles C
Biomaterials; 2005 Nov; 26(33):6704-12. PubMed ID: 15992921
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial chromogranins and proenkephalin-A-derived peptides: Antibacterial and antifungal activities of chromogranins and proenkephalin-A-derived peptides.
Metz-Boutigue MH; Goumon Y; Strub JM; Lugardon K; Aunis D
Ann N Y Acad Sci; 2003 May; 992():168-78. PubMed ID: 12794056
[TBL] [Abstract][Full Text] [Related]
8. Natural substrates of dipeptidyl peptidase IV.
De Meester I; Durinx C; Bal G; Proost P; Struyf S; Goossens F; Augustyns K; Scharpé S
Adv Exp Med Biol; 2000; 477():67-87. PubMed ID: 10849732
[No Abstract] [Full Text] [Related]
9. Presence of chromogranin-derived antimicrobial peptides in plasma during coronary artery bypass surgery and evidence of an immune origin of these peptides.
Tasiemski A; Hammad H; Vandenbulcke F; Breton C; Bilfinger TJ; Pestel J; Salzet M
Blood; 2002 Jul; 100(2):553-9. PubMed ID: 12091348
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart.
Corti A; Mannarino C; Mazza R; Angelone T; Longhi R; Tota B
Gen Comp Endocrinol; 2004 Apr; 136(2):217-24. PubMed ID: 15028525
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial and antifungal peptides derived from chromogranins and proenkephalin-A. From structural to biological aspects.
Metz-Boutigue MH; Lugardon K; Goumon Y; Raffner R; Strub JM; Aunis D
Adv Exp Med Biol; 2000; 482():299-315. PubMed ID: 11192590
[No Abstract] [Full Text] [Related]
12. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.
Briolat J; Wu SD; Mahata SK; Gonthier B; Bagnard D; Chasserot-Golaz S; Helle KB; Aunis D; Metz-Boutigue MH
Cell Mol Life Sci; 2005 Feb; 62(3):377-85. PubMed ID: 15723172
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.
Lugardon K; Raffner R; Goumon Y; Corti A; Delmas A; Bulet P; Aunis D; Metz-Boutigue MH
J Biol Chem; 2000 Apr; 275(15):10745-53. PubMed ID: 10753865
[TBL] [Abstract][Full Text] [Related]
14. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
[TBL] [Abstract][Full Text] [Related]
15. N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries.
Brekke JF; Osol GJ; Helle KB
Regul Pept; 2002 May; 105(2):93-100. PubMed ID: 11891009
[TBL] [Abstract][Full Text] [Related]
16. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
[TBL] [Abstract][Full Text] [Related]
17. Chromogranins: from discovery to current times.
Helle KB; Metz-Boutigue MH; Cerra MC; Angelone T
Pflugers Arch; 2018 Jan; 470(1):143-154. PubMed ID: 28875377
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure.
Strub JM; Hubert P; Nullans G; Aunis D; Metz-Boutigue MH
FEBS Lett; 1996 Feb; 379(3):273-8. PubMed ID: 8603705
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric identification of phosphorylated vasostatin II, a chromogranin A-derived protein fragment (1-113).
Zhang X; Dillen L; Bauer SH; Van Dongen W; Liang F; Przybylski M; Esmans E; De Potter WP; Claeys M
Biochim Biophys Acta; 1997 Dec; 1343(2):287-98. PubMed ID: 9434119
[TBL] [Abstract][Full Text] [Related]
20. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.
Angeletti RH; Aardal S; Serck-Hanssen G; Gee P; Helle KB
Acta Physiol Scand; 1994 Sep; 152(1):11-9. PubMed ID: 7810329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
